Swallowing it has randomized human trials behind it. Injecting it does not. That is the whole comparison, and everything below is the reason it survives scrutiny.
The confusion starts because the two formats do not contain the same thing. An injection delivers NAD⁺ itself. A capsule delivers a precursor — nicotinamide riboside or nicotinamide mononucleotide — which your body converts. Nobody swallows NAD⁺, because nobody needs to, and the trials that matter were all run on the precursor.
The objection the injection is sold on, answered
Every injection page you will read makes the same argument: oral NAD⁺ is broken down before it reaches your blood, so a needle is the only route that works. The first half is true and the second half does not follow, because the pill is not NAD⁺.
Oral bioavailability of the precursor has been measured directly. The first clinical trial of nicotinamide riboside pharmacokinetics in humans gave single doses of 100, 300 and 1,000 mg and found dose-dependent increases in the blood NAD⁺ metabolome; in a one-person pilot, blood NAD⁺ rose as much as 2.7-fold after a single oral dose [1]. A later eight-week randomized, double-blind, placebo-controlled trial in overweight but otherwise healthy adults gave the same three doses daily and raised whole blood NAD⁺ by 22%, 51% and 142% within two weeks, with the increases maintained for the rest of the study [2].
A molecule that moves whole blood NAD⁺ by 142% has not been destroyed in the gut. Whether NR or NMN is the better precursor is a separate argument, and we settle it in NMN vs NR.
What the injection has, counted rather than asserted
A PRISMA-guided systematic review published in early 2026 swept peer-reviewed human and rodent intervention studies of NAD-related compounds given orally or parenterally, from January 2010 to October 2025. It identified 113 eligible studies — 33 human intervention studies, 28 of them randomized — and reported that no eligible outcomes trial evaluated intravenous or intramuscular NAD⁺ itself for an anti-aging or wellness indication [3].
We checked the same ground independently in September 2026. A PubMed search for “nicotinamide adenine dinucleotide” and injection in the title or abstract, filtered to the randomized controlled trial publication type, returns nothing. Two control searches run the same day rule out a broken probe: the same phrase with randomized anywhere in the title or abstract returns 152 records, and the phrase alone returns 17,057. The database is answering. It has nothing to answer with.
The honest limit on the oral case
The trials above measured a blood level, not a benefit, and the same review that counted zero injection trials was equally blunt about the precursors: oral NR and NMN consistently demonstrated biochemical target engagement and were generally well tolerated over weeks to months, while effects on functional, metabolic and vascular outcomes were heterogeneous and often null or endpoint-specific [3].
So the oral format wins on evidence in a narrow, specific sense: it is the format where the mechanism has been shown to work in people. It has not shown that the mechanism produces the energy, focus or slowed aging the whole category advertises — no format has.
The price comparison nobody can make for you
Here is where this differs from every other format question on this site. When you compare an infusion against an injection, both bags contain NAD⁺ and cost per milligram settles it. Compare a capsule against an injection and that arithmetic breaks, because a milligram of nicotinamide riboside is not a milligram of NAD⁺. Dividing one by the other would produce a number that looks decisive and means nothing.
What can be compared is the bill. Tru Niagen lists $39.20 a month on subscription for a 300 mg daily serving of NR. System Labs lists $149 a month for an injection at a stated 1,000 mg. Both publish a quantity, which is rare enough in this category to be worth saying out loud — most injection sellers publish no milligram figure at all, which makes their prices uncomparable with each other, never mind with a capsule. The price comparison tool keeps the unit attached to every figure for exactly that reason.
When the needle is still the right answer
There is one. If you have a reason to bypass the gut — a malabsorption condition, a surgical history, a clinician who has told you oral supplementation will not reach you — that is a medical conversation with a real indication behind it, and it is not the conversation a wellness subscription page is having with you.
Absent that, the injection is asking you to pay several times more for the format with no controlled outcome trials, on an absorption argument that does not apply to the product it is being compared against. Both the injectable and the intravenous versions arrive compounded, meaning they are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before they are dispensed. If you want to see what the needle costs anyway, the injection board lists verified prices; if you want the route the trials used, the supplement board does the same.